Trial results show artificial pancreas reduces risk of overnight hypoglycemia
JDRF funded trails at Cambridge University have shown that an artificial pancreas dramatically reduces the risk of potentially deadly hypoglycemia.
Published today in the respected journal The Lancet, JDRF-funded researchers developed and successfully tested an automated management system, which was able to predict and prevent blood sugar fluctuations. Dramatic blood sugar drops, or hypoglycemia, have immediate and often devastating consequences and have an enormous impact on both individuals and families living with type 1 diabetes.
6 Comments 
In a significant breakthrough for people with diabetes, JDRF has formed a partnership with two international companies to produce an automated diabetes management system to eliminate the need for insulin injections and dramatically reduce the risk of life threatening health complications.
Two major JDRF-funded studies in the US have shown that continuous glucose monitors (CGMs) deliver better diabetes control with regular use for all age groups, while also reducing the frequency of hypoglycemia, or dangerously low blood glucose levels that can lead to coma or death.



